HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sahenk, Z. Articles by Freimer, M. Search for Related Content PubMed PubMed Citation Articles by Sahenk, Z. Articles by Freimer, M.

A novel PMP22 point mutation causing HNPP phenotype

Studies on nerve xenografts

From The Ohio State University, Department of Neurology, Neuromuscular Disease Center, Columbus, OH.

Address correspondence and reprint requests to Dr. Sahenk, The Ohio State University Department of Neurology, 1654 Upham Drive, Columbus, OH 43210.

Background: Hereditary neuropathy with liability to pressure palsies (HNPP) in most cases is caused by a deletion in chromosome 17p11.2-12 or, rarely, mutations resulting in a functional loss of one copy of the peripheral myelin protein 22 (PMP22) gene. Point mutations that lie deep within transmembrane(TM) domains causing major structural changes in PMP22 are associated with severe neuropathy.

Methods: A 25-year-old asymptomatic woman with a normal neurologic examination volunteered as a control subject. Electrophysiologic studies showed multiple entrapment neuropathies, prompting a search for a genetic defect. In addition, sural nerve fascicles from the subject were grafted into the cut ends of the sciatic nerve of nude mice and studied at 2, 6, and 8 weeks and compared with controls.

Results: Direct sequencing of the PMP22 gene revealed a GA transition at position 202 in axon 3 of the PMP22 gene. To determine if this was a causative mutation rather than a polymorphism, 102 DNA samples from controls were studied; none showed a similar base pair change. In the nerve xenografts, there was a marked delay at the onset of myelination and an impairment in the regenerative capacity of the nude mice axons engulfed by the mutant human Schwann cells. The axon tips were enlarged and demonstrated neurofilament density increase. Neurofilament density distribution histograms were bimodal in xenografts as well as in the subject's sural nerve.

Conclusion: This study provides unequivocal evidence that a base pair change causing a Val30Met substitution at the junction of the first TM domain and the extracellular loop of PMP22 results in the HNPP phenotype.

Supported by a grant from the Muscular Dystrophy Association.

Received March 3, 1998. Accepted in final form April 10, 1998.

This article has been cited by other articles:

				Z. Sahenk, H. N. Nagaraja, B. S. McCracken, W. M. King, M. L. Freimer, J. M. Cedarbaum, and J. R. Mendell NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients Neurology, September 13, 2005; 65(5): 681 - 689. [Abstract] [Full Text] [PDF]

				H. Nodera, M. Nishimura, E. L. Logigian, D. N. Herrmann, and R. Kaji HNPP due to a novel missense mutation of the PMP22 gene Neurology, June 10, 2003; 60(11): 1863 - 1864. [Full Text] [PDF]

				F. Stogbauer, P. Young, G. Kuhlenbaumer, P. De Jonghe, and V. Timmerman Hereditary recurrent focal neuropathies: Clinical and molecular features Neurology, February 8, 2000; 54(3): 546 - 546. [Abstract] [Full Text] [PDF]